midazolam in dextrose 5%, 50 mg/50 mL, (1 mg/mL), 50 mL Syringe, Rx only, Central Admixture Pharm...

FDA Recall #D-0018-2024 — Class II — September 21, 2023

Recall #D-0018-2024 Date: September 21, 2023 Classification: Class II Status: Terminated

Product Description

midazolam in dextrose 5%, 50 mg/50 mL, (1 mg/mL), 50 mL Syringe, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC 71286-4036-1

Reason for Recall

Lack of assurance of sterility:

Recalling Firm

Central Admixture Pharmacy Services Inc — San Diego, CA

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

419 50 mL syringes

Distribution

Nationwide in the USA

Code Information

Lot: 17-275475, Exp. 10/4/2023; 17-276117, Exp. 10/17/2023

Status

Terminated

Voluntary / Mandated

Voluntary: Firm initiated